You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
14 October 2026 - Radiopharmaceutical company Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) announced on Wednesday that it will present 20 company-related abstracts at the 39th European Association of Nuclear Medicine (EANM) Annual Congress i...
14 October 2026 - CTC intelligence company CelLBxHealth plc (AIM: CLBX) reported on Wednesday that it has signed a new Statement of Work (SOW) worth approximately USD65,000 under an existing Master Services Agreement with a US-based pharmaceutical co...
14 October 2026 - Medical technology company Vantis Vascular announced on Tuesday that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for a new 6 French (6F) model of its CrossFAST Integrated Microcatheter Advanced De...
13 October 2026 - Racura Oncology Limited (ASX:RAC), a late clinical-stage biopharmaceutical company, announced on Monday that the Safety Review Committee (SRC) for the Phase 1 HARNESS-1 trial has approved its lead oncology drug, RC220, to proceed to...
13 October 2026 - Blue Lake Biotechnology Inc, a clinical-stage intranasal vaccine company, on Monday reported the presentation of interim data from the company's Phase 1/2a paediatric clinical trial of RSV vaccine candidate BLB201 as a late-bre...
13 October 2026 - Japanese electrical products manufacturer TWINBIRD Corporation (TOKYO:6897) on Tuesday announced the SC-UF25 Ultra-Low Temperature Portable Freezer, a compact 25-litre unit capable of reaching −86 degrees C, with commercial re...
13 October 2026 - Solvonis Therapeutics plc (LON:SVNS), a late clinical-stage biopharmaceutical company developing small-molecule therapeutics for central nervous system (CNS) disorders, said on Tuesday that it has signed a memorandum of understandin...